These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31975156)

  • 21. Clinical implementation of PLANET® Dose for dosimetric assessment after [
    Santoro L; Pitalot L; Trauchessec D; Mora-Ramirez E; Kotzki PO; Bardiès M; Deshayes E
    EJNMMI Res; 2021 Jan; 11(1):1. PubMed ID: 33394212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is a single late SPECT/CT based kidney
    Beykan S; Tran-Gia J; Borup Jensen S; Lassmann M
    Phys Med; 2022 Aug; 100():39-50. PubMed ID: 35724608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-Invasive Imaging Methodologies for Assessment of Radiation Damage to Bone Marrow and Kidneys from Peptide Receptor Radionuclide Therapy.
    Ahlstedt J; Johansson E; Sydoff M; Karlsson H; Thordarson E; Gram M; Eriksson O
    Neuroendocrinology; 2020; 110(1-2):130-138. PubMed ID: 30999299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of image registration on 3D absorbed dose calculations in
    Grassi E; Fioroni F; Berenato S; Patterson N; Ferri V; Braglia L; Filice A; Versari A; Iori M; Spezi E
    Phys Med; 2018 Jan; 45():177-185. PubMed ID: 29472084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model.
    Hardiansyah D; Riana A; Beer AJ; Glatting G
    Z Med Phys; 2023 Feb; 33(1):70-81. PubMed ID: 35961809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog
    Zhang J; Wang H; Jacobson O; Cheng Y; Niu G; Li F; Bai C; Zhu Z; Chen X
    J Nucl Med; 2018 Nov; 59(11):1699-1705. PubMed ID: 29653971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose.
    Brosch-Lenz J; Ke S; Wang H; Frey E; Dewaraja YK; Sunderland J; Uribe C
    J Nucl Med; 2023 Jul; 64(7):1109-1116. PubMed ID: 37024302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [
    Santoro L; Mora-Ramirez E; Trauchessec D; Chouaf S; Eustache P; Pouget JP; Kotzki PO; Bardiès M; Deshayes E
    EJNMMI Res; 2018 Nov; 8(1):103. PubMed ID: 30498938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods.
    Belli ML; Mezzenga E; Di Iorio V; Celli M; Caroli P; Canali E; Matteucci F; Tardelli E; Grassi I; Sansovini M; Nicolini S; Severi S; Cremonesi M; Ferrari M; Paganelli G; Sarnelli A
    J Vis Exp; 2020 Apr; (158):. PubMed ID: 32391816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of dead time on quantitative
    Desy A; Bouvet GF; Frezza A; Després P; Beauregard JM
    EJNMMI Phys; 2020 May; 7(1):32. PubMed ID: 32415492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotate.
    Ezziddin S; Reichmann K; Yong-Hing C; Damm M; Risse J; Ahmadzadehfar H; Logvinski T; Guhlke S; Biersack HJ; Sabet A
    Nuklearmedizin; 2013; 52(5):170-7. PubMed ID: 23963021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective observational study of
    Garske-Román U; Sandström M; Fröss Baron K; Lundin L; Hellman P; Welin S; Johansson S; Khan T; Lundqvist H; Eriksson B; Sundin A; Granberg D
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):970-988. PubMed ID: 29497803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage PRRT with
    Rudisile S; Gosewisch A; Wenter V; Unterrainer M; Böning G; Gildehaus FJ; Fendler WP; Auernhammer CJ; Spitzweg C; Bartenstein P; Todica A; Ilhan H
    BMC Cancer; 2019 Aug; 19(1):788. PubMed ID: 31395036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment.
    Sandström M; Garske-Román U; Granberg D; Johansson S; Widström C; Eriksson B; Sundin A; Lundqvist H; Lubberink M
    J Nucl Med; 2013 Jan; 54(1):33-41. PubMed ID: 23223392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of kidney doses from [
    Spink S; Gillett D; Heard S; Harper I; Casey R; Aloj L
    EJNMMI Phys; 2024 Jul; 11(1):68. PubMed ID: 39052172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging.
    Jackson PA; Beauregard JM; Hofman MS; Kron T; Hogg A; Hicks RJ
    Med Phys; 2013 Nov; 40(11):112503. PubMed ID: 24320462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of simplifying renal dosimetry in
    Sundlöv A; Gustafsson J; Brolin G; Mortensen N; Hermann R; Bernhardt P; Svensson J; Ljungberg M; Tennvall J; Sjögreen Gleisner K
    EJNMMI Phys; 2018 Jul; 5(1):12. PubMed ID: 29974391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplified dosimetry for kidneys and tumors in
    Ardenfors O; Nilsson JN; Thor D; Hindorf C
    EJNMMI Phys; 2022 Jun; 9(1):44. PubMed ID: 35723797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized kidney dosimetry in
    Hou X; Zhao W; Beauregard JM; Celler A
    Phys Med Biol; 2019 Aug; 64(17):175004. PubMed ID: 31456584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.
    Garkavij M; Nickel M; Sjögreen-Gleisner K; Ljungberg M; Ohlsson T; Wingårdh K; Strand SE; Tennvall J
    Cancer; 2010 Feb; 116(4 Suppl):1084-92. PubMed ID: 20127957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.